(Q35149297)

6 August 2017

1 reference

title

Current approaches to novel therapeutics in pancreatic cancer (English)

1 reference

6 August 2017

1 reference

Corina E Akerele

1

1 reference

6 August 2017

Irina Rybalova

series ordinal

2

1 reference

6 August 2017

Howard L Kaufman

series ordinal

3

1 reference

6 August 2017

Sridhar Mani

series ordinal

4

1 reference

6 August 2017

publication date

1 February 2003

1 reference

Investigational New Drugs

6 August 2017

published in

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

113-129

1 reference

Preoperative combined modality therapy for pancreatic cancer

6 August 2017

cites work

1 reference

12 December 2020

Treatment perspectives in locally advanced unresectable pancreatic cancer

1 reference

12 December 2020

1 reference

12 December 2020

Genetic progression in the pancreatic ducts

1 reference

12 December 2020

1 reference

12 December 2020

Molecular pathobiology of pancreatic adenocarcinoma.

1 reference

12 December 2020

Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416

1 reference

12 December 2020

Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites.

1 reference

12 December 2020

Hereditary pancreatitis. Gene defects and their implications

1 reference

12 December 2020

A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma

1 reference

12 December 2020

p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma

1 reference

12 December 2020

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

12 December 2020

Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness

1 reference

12 December 2020

Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears

1 reference

12 December 2020

Antisense oligonucleotides to gastrin inhibit growth of human pancreatic cancer

1 reference

12 December 2020

Malignant neoplasms in the families of patients with ataxia-telangiectasia

1 reference

12 December 2020

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

1 reference

12 December 2020

Epidemiology and risk factors in pancreatic cancer

1 reference

12 December 2020

Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours

1 reference

12 December 2020

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

1 reference

12 December 2020

Hereditary pancreatitis and familial pancreatic cancer

1 reference

12 December 2020

Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations.

1 reference

12 December 2020

Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design

1 reference

12 December 2020

A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity

1 reference

12 December 2020

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

1 reference

12 December 2020

Chemotherapy prolongs survival in inoperable pancreatic carcinoma.

1 reference

12 December 2020

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy

1 reference

12 December 2020

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix

1 reference

12 December 2020

The epidermal growth factor receptor in human pancreatic cancer

1 reference

12 December 2020

Molecular pathology of pancreatic cancer

1 reference

12 December 2020

Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival

1 reference

12 December 2020

Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity

1 reference

12 December 2020

Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.

1 reference

12 December 2020

A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer

1 reference

12 December 2020

Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression

1 reference

12 December 2020

Ductal adenocarcinoma of the pancreas in MEN-1-patients.

1 reference

12 December 2020

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

12 December 2020

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

12 December 2020

Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing.

1 reference

12 December 2020

Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis

1 reference

12 December 2020

Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts

1 reference

12 December 2020

Novel therapies for pancreatic cancer.

1 reference

12 December 2020

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1 reference

12 December 2020

Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome.

1 reference

12 December 2020

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

1 reference

12 December 2020

Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

12 December 2020

Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms

1 reference

12 December 2020

Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis

1 reference

12 December 2020

Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+

1 reference

12 December 2020

Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective

1 reference

12 December 2020

Recent cancer trends in the United States

1 reference

12 December 2020

Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head

1 reference

12 December 2020

Cancer statistics, 2000.

1 reference

12 December 2020

(Neo)adjuvant treatment in pancreatic cancer--the need for future trials

1 reference

12 December 2020

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease

1 reference

12 December 2020

The potential for gene therapy in pancreatic cancer

1 reference

12 December 2020

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

1 reference

12 December 2020

Genetic progression and divergence in pancreatic carcinoma

1 reference

12 December 2020

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

1 reference

12 December 2020

High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer

1 reference

12 December 2020

Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage

1 reference

12 December 2020

Cancer statistics for African Americans

1 reference

12 December 2020

Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y.

1 reference

12 December 2020

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

12 December 2020

Matrix metalloproteinase inhibition: a review of anti-tumour activity

1 reference

12 December 2020

Pancreatic lesions in the von Hippel-Lindau syndrome

1 reference

12 December 2020

Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study

1 reference

12 December 2020

Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole

1 reference

12 December 2020

Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer

1 reference

12 December 2020

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

12 December 2020

Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation

1 reference

12 December 2020

1 reference

12 December 2020

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

12 December 2020

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene

1 reference

12 December 2020

HER-2/Neu expression as a progression marker in pancreatic intraepithelial neoplasia

1 reference

12 December 2020

Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol

1 reference

12 December 2020

Adjuvant or neoadjuvant therapy for pancreatic carcinoma?

1 reference

12 December 2020

Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast

1 reference

12 December 2020

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

1 reference

12 December 2020

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

12 December 2020

Relation of pancreatic duct hyperplasia to carcinoma

1 reference

12 December 2020

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

12 December 2020

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression

1 reference

12 December 2020

Continuing controversy over adjuvant therapy of pancreatic cancer

1 reference

12 December 2020

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022936914328

1 reference

Dimensions Publication ID

6 August 2017

1006473519

0 references

1 reference